The SRT-100™ treats the following conditions: Squamous cell carcinoma Basal cell carcinoma Metatypical carcinoma Keloid scars Actinic keratosis Kaposi’s sarcoma Cutaneous appendage carcinoma
Comparable to surgery, the cure rate of basal and squamous cell skin cancer is 95% when treated with the SRT-100™.
How effective is the SRT-100™ at treating Keloids?
The SRT-100™ is 90% effective in treating Keloids.
Treatments are short and last less than a minute. Some cases require several treatments per week for up to several weeks, depending on the treatment plan your physician will customize for you.
Is the SRT-100™ a safe option for cancer treatment? The SRT-100™ is used by dermatologists and radiation oncologists globally as an effective, safe, and proven option for treating non-melanoma skin cancers, Keloids, actinic keratosis, and Kaposi’s sarcoma.
The SRT-100™ is an excellent alternative to surgery because it targets cancer cells without posing harm to the surrounding or underlying tissue. Additional benefits include:
- No cutting
- No pain
- No bleeding
- No anesthesia
- No stitching
- No scarring
- No interruption of lifestyle
- No reconstructive surgery
Since the SRT-100™ is non-invasive, patients do not need to worry about any post-treatment scarring that may require surgery.
The SRT-100™ is approved by the Federal Drug Administration for use on the entire body.